← Insider buys
RUBY

Rubius Therapeutics, Inc.

Director Robert Langer sold $112K of Rubius Therapeutics, Inc.

Sold$112,049
$14.94Price
7,500Shares
−100%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Mon, Jul 15. Filed Wed, Jul 17, 12:14 PM ET, during the session. Not investment advice.